2-3 February, 2022  |  Online Conference
This virtual conference was jointly organised by GARDP and the BSAC. This conference is RCPath CPD accredited.
Abstract submission
For 2022, we collaborated with the Center For Disease Dynamics, Economics & Policy (CDDEP) and the Indian Council of Medical Research (ICMR).

Programme

Recorded content from this conference can be viewed below.

SESSION ONE: KEYNOTE PRESENTATION

View session one. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

Regulatory challenges and global access to new antibiotics

Dr Ramanan Laxminarayan, Director, CDDEP - View Bio

SESSION TWO: Early drug discovery: new targets and new chemistry

View session two. This video consists of the following presentations:

Watch Presentation

Dual fluorescent timer module for screening of anti-persister agents

Professor Ranjana Pathania, Professor Indian Institute of Technology Roorkee (IIT Roorkee) - View Bio

Discovery and optimization of β-sliding clamp (DnaN) inhibitors

Professor Dr Anna Hirsch, Head of department, Drug Design and Optimization (DDOP) Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - View Bio

New ways to identify novel antibacterial chemical entities - Identification of Novel Antibacterials Using Machine Learning Techniques

Mr Ed Siegwart, Director of Microbiology, Oppilotech Ltd - View Bio

Q&A

SESSION THREE: Preclinical antimicrobial development

View session three. This video consists of the following presentations:

Watch Presentation

WHO Priority pathogen list and WHO preclinical pipeline analysis

Dr Valeria Gigante, Team Lead, One Health Research Priority-setting and Synergy in AMR, WHO - View Bio

Overview of CARB-X pipeline

Dr Erin Duffy, Chief of Research & Development, CARB-X - View Bio

SESSION FOUR: Panel Discussion

View session four. This video consists of the following presentations:

Watch Presentation

Panellist

Dr Susan Hopkins - View Bio

Panellist

Dr Priscilla Rupali - View Bio

Panellist

Dr Subasree Srinivasan - View Bio

Panellist

Prof. Dr Evelina Tacconelli - View Bio

Day one closing remarks

Dr Christopher Longshaw, Senior Director, EU Scientific Affairs, Shionogi BV & BSAC Honorary Treasurer - View Bio

SESSION FIVE: Clinical development

View session five. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer - View Bio

Overview of clinical pipeline for antimicrobials - will it meet the future unmet need?

Professor Mical Paul, Head, Division of Infectious Diseases, Rambam Health Care Campus, Israel - View Bio

Emerging antibiotic market in the Indian subcontinent

Mr Anmol Aggarwal, Lead, R&D Strategy, Venus Medicine Research Centre, India - View Bio

Clinical development of non-traditional antibiotics

Dr Balganesh Tanjore Soundararajan, President, Gangagen Biotechnologies Pvt Ltd, Bangalore, India - View Bio

Q&A

SESSION SIX: Oral Poster Presentations

View session six. This video consists of the following presentations:

Watch Presentation

Evaluating the veterinarian role in one health approach at antimicrobial resistance perspectives, Jordan

Bazzi Randa, Faculty of Public Health, University of Debrecen - View Bio

The ESKAPE pathogens mobilome

João Botelho, Postdoctoral Researcher, Max Planck Institute for Evolutionary Biology - View Bio

Utilising health belief model to assess antimicrobial awareness of Western Australian parents: A qualitative study

Aaron Alejandro, PhD Candidate, Murdoch University Australia - View Bio

Nanobodies as inhibitors of the SOS-response: a new class of potential suppressors of antimicrobial resistance

Filippo Vascon, PhD student, Università degli Studi di Padova - View Bio

Phage mediated beta-lactamases and carbapenemases in multi-drug resistant Escherichia coli

Juliet Roshini Mohan Raj, Assistant Professor, Nitte University Centre for Science Education and Research - View Bio

Q&A

SESSION SEVEN: Impact of the COVID-19 pandemic on infections and antimicrobial resistance

View session seven. This video consists of the following presentations:

Watch Presentation

Impact of Covid 19 on Antimicrobial stewardship

Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio

How has Indian AMR data changed post-Covid

Dr Kamini Walia, Program officer AMR Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research - View Bio

Impact of Covid-19 on treatment of fungal infections

Dr Arunaloke Chakrabarti, President of International Society for Human and Animal Mycology (ISHAM) - View Bio

Q&A

SESSION EIGHT: Panel Discussion - More than one way to do it – R&D of new antimicrobials: incentives and models

View session eight. This video consists of the following presentations:

Watch Presentation

Panellist

Dr Anand Anandkumar, Dr Jean-Pierre Paccaud, Ms Jenny Hellmann - View Bio

Panellist

Dr Anand Anandkumar, Co-Founder & CEO of Bugworks - View Bio

Panellist

Dr Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy Global Antibiotic R&D Partnership (GARDP) - View Bio

Panellist

Ms Jenny Hellmann, Assistant chief of Antibiotics and Infection control unit, Public Health Agency of Sweden - View Bio

Closing remarks

Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

Virtual poster gallery

Click here to view the virtual poster gallery from the conference